CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing)....
Phase 1
Austin, Texas, United States and 6 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Austin, Texas, United States and 66 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Austin, Texas, United States and 55 other locations
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Round Rock, Texas, United States and 126 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Austin, Texas, United States and 215 other locations
of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comp...
Phase 1
Austin, Texas, United States and 6 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Austin, Texas, United States and 73 other locations
by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:* Find the recommended dose...
Phase 1, Phase 2
Austin, Texas, United States and 9 other locations
This trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combi...
Phase 2
Austin, Texas, United States and 75 other locations
This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...
Phase 3
Austin, Texas, United States and 226 other locations
Clinical trials
Research sites
Resources
Legal